To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01301391
Title Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tiziana Life Sciences, PLC
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA


No variant requirements are available.